Download Center

You Have Requested The File: IndiaNivesh_Pharma_Sector_Review_July_2014.pdf

Please Wait. Your File Is Being Retrieved From The Server. It will Take 30 seconds

Problems? Use this alternate download link

TVS Motor: Healthy Volume Growth: Karvy
Valuation & Rating: In view of TVSL gaining market shares, better industry outlook and healthy exports, we increase our volume estimates by 8% and 9.5% for FY15 and FY16, accordingly we increa .....
Buy TVS Motor; target of Rs 175: Sharekhan
The TVS management is looking to leverage on a complete scooter portfolio in FY2015. It also expects motorcycle volumes, which were lacklustre in FY2014, to pick up in FY2015 aided especially by th .....
Dish TV has several catalysts: Goldman Sachs
Several catalysts lined up; Favorable risk-reward; Maintain Buy

Source of opportunity

We retain our Buy on Dish TV as we expect the company to benefi .....

Sunil Singhania's Abakkus has bought 10.69L shares of Aarti Pharma at ₹575 for ₹61.5 Cr Sunil Singhania's Abakkus has bought 10.69L shares of Aarti Pharma at ₹575 for ₹61.5 Cr. M-Cap is ₹5800 Cr. Promoters hold 46%. Co operates in 3 areas i.e. Xanthine derivatives, API & C .....
PNB Housing is undergoing a transformation to morph into a franchise that will be stronger PNB Housing is undergoing a transformation to morph into a franchise that will be stronger, more resilient & with high predictability in earnings trajectory. Risk-reward profile is favorable for a .....
Piramal Pharma is seeing strong momentum in CDMO. Buy for TP ₹320 (27% upside) Piramal Pharma is seeing strong momentum in CDMO. Postponement of the Biosecure Act is unlikely to cause growth related issues as China rebalancing drive by global innovators likely to continue. Other .....